Lv62
2860 积分 2024-01-18 加入
Towards biomarker-driven therapies for urothelial carcinoma
4小时前
待确认
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
1天前
待确认
Lines of Therapy for Locally Advanced/Metastatic Urothelial Carcinoma: The New Paradigm
6天前
已完结
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies
7天前
已完结
Top advances of the year: Bladder cancer
8天前
已完结
Muscle-Invasive Bladder Cancer: A Watershed Moment
8天前
已完结
Advances in the management of localized bladder cancers
12天前
已完结
Intravesical gemcitabine versus anthracyclines for primary and first recurrent non-muscle-invasive bladder cancer: a single-center retrospective study over 10 years
21天前
已完结
Advances in the management of localized bladder cancers
21天前
已完结
The evolving treatment landscape of metastatic urothelial cancer
21天前
已完结
皖公网安备34019202002308
